Raymed Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2025 ,inter alia, to consider and approve Please find the attached Intimation ....
Awaiting price reaction for this filing.
Cresanto Global Limited has informed BSE that its Board of Directors will meet on Wednesday, 5 November 2025 at the corporate office. The key agenda is to consider and approve the unaudited financial results for the second quarter and half year ended 30 September 2025, along with the Limited Review Report from auditors. The company has also declared a trading window closure for designated persons from 1 October 2025 to 7 November 2025, which is standard practice ahead of results declaration. The intimation is filed under SEBI Listing Regulations, 2015. No financial figures or business details have been disclosed in this notice — those will come after the board meeting.
This is a routine regulatory filing ahead of quarterly results. Shareholders should watch for the actual Q2/H1 FY26 numbers, expected around 5–7 November 2025, which could move the stock depending on performance versus expectations.